← Back to all trials
Completed
NCT06545916
Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder
Conditions: Alcohol Use Disorder
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE2
Enrollment: 209
Sponsor: Knoa Pharma LLC
Location: Belmont Medical Office Brooklyn New York
Summary
The purpose of this study is to evaluate the efficacy of sunobinop compared to placebo on alcohol consumption in subjects with alcohol use disorder.
Eligibility Criteria
Key Inclusion Criteria include:
* Male and female age ≥18 years.
* Diagnosis of moderate or severe alcohol use disorder.
* Currently seeking treatment for alcohol use disorder.
* Has 4 or more heavy drinking days (HDD) in each of the 4 weeks prior to baseline visit.
Key Exclusion Criteria include:
* Subjects that meet current DSM-5 criteria for moderate or severe substance use disorder other than alcohol and nicotine.
Other protocol-specific inclusion and exclusion criteria may apply.
Source: ClinicalTrials.gov (NCT06545916). StuddyBuddy aggregates publicly available trial information.
